Article
Two distinct classes of thymic tumors in patients with MEN1 show LOH at the MEN1 locus
13 Sept 2021
Abstract excerpt
Patients with the multiple endocrine neoplasia type 1 (MEN1) syndrome carry germline heterozygous loss-of-function mutations in the MEN1 gene which predisposes them to develop various endocrine and non-endocrine tumors. Over 90% of the tumors show loss of heterozygosity (LOH) at chromosome 11q13, the MEN1 locus, due to somatic loss of the wild-type MEN1 allele. Thymic neuroendocrine tumors (NETs) or thymic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
